glp-1 conversion and Its Role in Glycogen Production: A Narrative Review Mounjaro? Ozempic? Wegovy? Why's everyone

Regulation of Na+/H+ exchanger NHE3 by glucagon-like peptide 1 receptor agonist exendin-4 in renal proximal tubule cells

A caveat of using these medications is that many have reduced renal clearance due to declining kidney function or are contraindicated and often require careful dose adjustments [11,12,13]

The dose depends on it

Design and baseline characteristics of the STRIDE trial: evaluating semaglutide in people with symptomatic peripheral artery disease and type 2 diabetes

If hair shedding begins three to six months after starting GLP-1 therapy and is diffuse rather than patchy or patterned, GLP-1 related telogen effluvium is the most likely cause

Other NASH-related biomarkers were decreased, and adiponectin was increased in patients with T2DM [62]